The Oncology Insights Podcast - Ewen Ward: 16th World ADC London Summit | Ep. 7

In this episode of The Oncology Insights Podcast, Dr. Abbie Begnaud speaks with Ewen Ward, Brand Director at Hanson Wade Group, about the scientific progress and future challenges shaping antibody drug conjugates in oncology. Ewen covers ADC design, toxicity considerations, clinical success, and how global collaboration through the 16th World ADC London Summit is influencing innovation. Listen now on all major platforms!

What you’ll learn: 

• ADC development trends
• Payload innovation strategies
• Clinical ADC challenges
• Conference-driven collaboration
• Patient-focused design

Meet the guest:

Ewen Ward is Brand Director at the Hanson Wade Group, where he leads the development of global scientific conferences focused on antibody-drug conjugates. With a background in biochemistry, his work centers on translating scientific challenges into impactful oncology agendas. 

Hear Ewen Ward share insights on ADC innovation and collaboration on The Oncology Insights Podcast, available on all major platforms. Connect with our guest on Social Media: LinkedIn 

Discover the full insights from the 16th World ADC London Summit. Access the complete Event Guide and full details here

Liked this one? Don’t stop now. Here’s what we think you’ll love!